W Oliver Tobin - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

W Oliver Tobin

Showing results (91-100 of 130) with videos related to

Pageof 13

Sort By:

Annals of Neurology|July 20, 2024

Cerebrospinal Fluid Cytokine and Chemokine Profiles in Central Nervous System Sarcoidosis: Diagnostic and Immunopathologic InsightsGeorgios Mangioris, Sean J Pittock, Binxia Yang, et al.

The Oncologist|September 28, 2020

Efficacy of BRAF-Inhibitor Therapy in BRAFV600E -Mutated Adult Langerhans Cell HistiocytosisAntonious Z Hazim, Gordon J Ruan, Aishwarya Ravindran, et al.

Mayo Clinic Proceedings|September 2, 2019

The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman DiseaseGaurav Goyal, Jason R Young, Matthew J Koster, et al.

Journal of Neurology|July 13, 2026

Clinical course of critical demyelinating lesion-associated progressive multiple sclerosisTuba S Chaudhry, Nabeela Nathoo, Bianca Albites Coen, et al.

The Oncologist|May 31, 2022

Impact of a Multidisciplinary Tumor Board on the Care of Patients with Histiocytic Disorders: The Histiocytosis Working Group experienceGaurav Goyal, Jason R Young, Jithma P Abeykoon, et al.

Multiple Sclerosis and Related Disorders|August 30, 2024

Multiple sclerosis in Somali Americans: Nature or nurture?Nabeela Nathoo, Nur Neyal, Elizabeth J Atkinson, et al.

British Journal of Haematology|February 18, 2026

Systemic Xanthogranuloma or Erdheim-Chester disease: A systematic review re-examining the classification challengeVyshnavi Rallapalle, Sailesh I S Kumar, Brinda Shukla, et al.

Neurology. Genetics|September 11, 2025

Clinical Practice Guidelines for the Diagnosis, Management, and Surveillance of LMNB1-Related Autosomal Dominant LeukodystrophyRadhika Dhamija, W Oliver Tobin, Pietro Cortelli, et al.

Journal of Neurology|April 29, 2025

Utility of spinal cord axial-T2 sequence in a population-based cohort of multiple sclerosisLaura Cacciaguerra, Ajay Madhavan, Elia Sechi, et al.

Journal of the Neurological Sciences|January 13, 2026

The impact of adding optical coherence tomography in MS diagnostic criteria on the classification of tumefactive demyelinationFiorella S Guido, John J Chen, Paul A Decker, et al.

Pageof 13

Search research articles

Showing results (91-100 of 130) with videos related to

Sort By:

Pageof 13

Annals of Neurology|July 20, 2024

Cerebrospinal Fluid Cytokine and Chemokine Profiles in Central Nervous System Sarcoidosis: Diagnostic and Immunopathologic InsightsGeorgios Mangioris, Sean J Pittock, Binxia Yang, et al.

The Oncologist|September 28, 2020

Efficacy of BRAF-Inhibitor Therapy in BRAFV600E -Mutated Adult Langerhans Cell HistiocytosisAntonious Z Hazim, Gordon J Ruan, Aishwarya Ravindran, et al.

Mayo Clinic Proceedings|September 2, 2019

Journal of Neurology|July 13, 2026

Clinical course of critical demyelinating lesion-associated progressive multiple sclerosisTuba S Chaudhry, Nabeela Nathoo, Bianca Albites Coen, et al.

The Oncologist|May 31, 2022

Impact of a Multidisciplinary Tumor Board on the Care of Patients with Histiocytic Disorders: The Histiocytosis Working Group experienceGaurav Goyal, Jason R Young, Jithma P Abeykoon, et al.

Multiple Sclerosis and Related Disorders|August 30, 2024

Multiple sclerosis in Somali Americans: Nature or nurture?Nabeela Nathoo, Nur Neyal, Elizabeth J Atkinson, et al.

British Journal of Haematology|February 18, 2026

Systemic Xanthogranuloma or Erdheim-Chester disease: A systematic review re-examining the classification challengeVyshnavi Rallapalle, Sailesh I S Kumar, Brinda Shukla, et al.

Neurology. Genetics|September 11, 2025

Clinical Practice Guidelines for the Diagnosis, Management, and Surveillance of LMNB1-Related Autosomal Dominant LeukodystrophyRadhika Dhamija, W Oliver Tobin, Pietro Cortelli, et al.

Journal of Neurology|April 29, 2025

Utility of spinal cord axial-T2 sequence in a population-based cohort of multiple sclerosisLaura Cacciaguerra, Ajay Madhavan, Elia Sechi, et al.

Journal of the Neurological Sciences|January 13, 2026

The impact of adding optical coherence tomography in MS diagnostic criteria on the classification of tumefactive demyelinationFiorella S Guido, John J Chen, Paul A Decker, et al.

Pageof 13